Nagapetir represents a novel treatment strategy targeting engaged protein C, a crucial element in the coagulation cascade. This molecule functions as a targeted factor blocker, demonstrating potential in lessening thrombotic events. Preclinical research have shown positive data, suggesting that Nagapetir may present a new option for the reductio… Read More